News & Events
The Drugs Technical Advisory Board has examined the issue of suspension of manufacture and sale of Pioglitazone on 19th July 2013 & has recommended that the Suspension of the drug should be revoked and allowed to be marketed subject to certain conditions the manufacturers shall mention on their package insert and promotional literature of the drug. Based on DTAB report Ministry of health & family welfare & Central Government revokes the notification G.S.R.379(E) dated 18th June 2013.
A new study presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism shows that one in eight patients are at risk of developing a serious adverse drug event (ADE) after taking, over the counter (OTC) non-steroidal anti-inflammatory drugs (NSAIDs), often to treat a musculoskeletal complaint. Possible serious ADEs include gastrointestinal bleeding, peptic ulceration, high blood pressureand worsening heart failure.
Researchers reported at the American Heart Association's 50th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, that the increase in sugar consumption has led to more diabetes and heart disease over the past decade.
People taking statin drugs to lower their cholesterol may slightly increase their risk for muscle and joint diseases as well as strains and sprains, a new study suggests. The results were published online June 3 in the journal JAMA Internal Medicine.

Slideshow Image 1
Slideshow Image 2
Slideshow Image 1
Slideshow Image 2
Slideshow Image 1
Cadell Healthcare Pvt Ltd. was established with a team of young, dynamic & experienced people in the year 2008. The name Cadell stands for Battle in welsh. In the Battle against deadly lifestyle diseases, We are always committed in Saving Life Together with medical fraternity, social organizations & the society.

Our core commitment is towards improving health care and creating value for all our stakeholders including doctors, patients, regulators, employees and business partners. We are passionate and enthusiastic about our goal and highly optimistic about our future in view of the exciting opportunities of expansion and growth at different stages of development.

Cadell Healthcare promises to continue providing high quality medicines manufactured in WHO-GMP facilities with good R&D backup. The prime objective of the company is to become most admired company by doctors, patients, employees and all channel partners.


Our mission is to give superior products having high quality standards at affordable cost & to improve the quality standards of the society to enable them to lead healthier, happier and more active lives.

With the available resources, we have a vision to expand our presence across the world & become the most successful, respected and patient friendly pharmaceutical company.


Customer Commitment: We develop relationships that make a positive difference in our customers’ lives.

Integrity: We uphold the highest standards of integrity in all of our actions.

We work together, across boundaries, to meet the needs of our customers and to help the company to achieve it's goal.




Home | About Us | Products | Enquiry | Contact Us | Order | Carrer
  All Rights Reserved By : Cadell Health care Pvt Ltd. Designed & Maintained By : Daffodil Design & Prints